Nanotechnology in Medical Applications: The Global Market

Apr 2022| HLC069E| BCC Publishing
Sample Report

Report Highlights

The global market for nanomedicine should grow from $242.6 billion in 2021 to $493.5 billion by 2026 with a compound annual growth rate (CAGR) of 15.3% for the period of 2021-2026.

Report Includes

  • 24 tables
  • An overview of the global markets for nanotechnology used in medical applications
  • Estimation of the market size, and analyses of the global market trends with data from 2019, 2020, 2021, with projection of CAGR through 2026
  • A review of technologies involved, in-depth analysis of applications in practice, and evaluation of future or potential applications
  • Information on significant products in which the nano dimension has made a significant contribution to product effectiveness
  • A look at the regulatory environment, healthcare policies, demographics, and other factors that directly affect nanotechnology used in medicine
  • Identification of key market dynamics, trends, opportunities, and factors influencing the global market and highlights of the market potential for nanotechnology used in medical applications based on type, application, and region
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Company profiles of major players in the market, including Abbott, Abraxis Bioscience, Elan, Orthovita Inc., EyePoint Pharmaceuticals Inc. and Farfield Scientific Ltd.

Report Scope

This report examines the current and forecast market potential for nanomedicine. It offers a detailed analysis of the market background, technological advancements, competitive environment, drivers and restraints, and market growth trends. This report includes market projections through 2026, detailing the market share for nanomedicine based on therapeutic areas and geography.

By therapeutic area, the nanomedicine market is segmented into anticancer, CNS products, anti-infectives, anti-inflammatories, cardiovascular, and others. By geography, the nanomedicine market has been segmented into Europe, North America, Asia-Pacific (APAC), and the Rest of the Word (ROW). The detailed analyses of major countries such as the U.S., Germany, Canada, the U.K., Spain, Italy, France, Japan, India, and China are included in the regional segments. For market estimates, data is provided for 2020 as the base year, 2021 and forecast through year-end 2026. Estimated values used are based on nanomedicine companies’ total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Frequently Asked Questions (FAQs)

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2020
Forecast period considered 2021-2026
Base year market size $193.6 billion
Market size forecast $445.2 billion
Growth rate CAGR of 15.1% from 2021 to 2026
Units considered $ Billions
Segments covered Type, Therapeutic Area, Region
Regions covered North America, Europe, Asia-Pacific, Rest of the World (RoW)
Countries covered U.S., Canada, Germany, France, U.K., Spain, Italy, Rest of Europe, Japan, China, India, Rest of Asia-Pacific
Companies studied
  • ABBOTT
  • ABRAXIS BIOSCIENCE (CELGENE {BRISTOL MYERS SQUIBB})
  • APHIOS CORP.
  • BIOFORCE NANOSCIENCES HOLDINGS INC.
  • C SIXTY INC. (ARROWHEAD PHARMACEUTICALS)
  • ELAN (ALKERMES)
  • EYEPOINT PHARMACEUTICALS INC. (FORMERLY PSIVIDA LTD.)
  • FARFIELD SCIENTIFIC (BIOLIN SCIENTIFIC AB)
  • KLEINDIEK NANOTECHNIK GMBH
  • LIPLASOME PHARMA APS
  • MAGFORCE NANOTECHNOLOGIES
  • MICROFLUIDICS CORP.
  • NANOBIO CORP. (BLUEWILLOW BIOLOGICS)
  • NANOBIOTIX SA
  • NANOCARRIER CO., LTD.
  • NANOCOPOEIA, LLC.
  • NANOLOGIX INC.
  • NANOMIX INC.
  • NANOSPECTRA BIOSCIENCES INC.
  • NANOSTRUCTURES INC.
  • ORTHOVITA INC. (STRYKER CORP.)
  • PFIZER INC.
  • SANOFI S.A.
  • STARPHARMA
  • TECANGROUP LTD.
  • TRANSGENEX NANOBIOTECH INC.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
. Title/Chapter NamePagesPrice Member Price
Full Report: Nanotechnology in Medical Applications: The Global Market100 $2,750 Free
Chapter- 1: Introduction8Free DownloadFree
Chapter- 2: Summary and Highlights3$250Free
Chapter- 3: Market Overview 32$880Free
Chapter- 4: Impact of COVID-19 Pandemic3$83Free
Chapter- 5: Markets for Nanomedicine 11$303Free
Chapter- 6: Global Nanomedicine Market Breakdown by Region15$413Free
Chapter- 7: Competitive Landscape3$83Free
Chapter- 8: Company Profiles25$688Free
Published - Nov-2017| Analyst - Paul Evers| Code - HLC069D

Report Highlights

The global nanomedical market was valued at $134.4 billion in 2016. This market is projected to grow at a compound annual growth rate (CAGR) of 14.0% from 2017-2022, and should reach $293.1 billion by 2022 from $151.9 billion in 2017.

Report Includes

  • An overview of the global markets for nanotechnology used in medical applications
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • A review of technologies involved, in-depth analysis of applications in practice, and evaluation of future or potential applications
  • Information on many significant products in which the nano dimension has made a significant contribution to product effectiveness
  • A look at the regulatory environment, healthcare policies, demographics, and other factors that directly affect nanotechnology used in medicine
  • Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities
  • Coverage of strategies employed by companies specializing in nanomedicine to meet the challenges of this highly competitive market
Published - Sep-2015| Analyst - Paul Evers| Code - HLC069C

Report Highlights

Global nanomedicine market was valued at $214.2 billion in 2013 and $248.3 billion in 2014. The total market is projected to grow at a compound annual growth rate (CAGR) of 16.3% from 2014 through 2019 and reach $528 billion by 2019.

Report Includes

  • An overview of the global markets for nanotechnology used in medical applications.
  • Analyses of global market trends, with data from 2012 to 2014, and projections of CAGRs through 2019.
  • A review of technologies involved, in-depth analysis of applications in practice, and evaluation of future or potential applications.
  • Information on a number of significant products in which the nano dimension has made a significant contribution to product effectiveness.
  • A look at the regulatory environment, healthcare policies, demographics, and other factors that directly affect nanotechnology used in medicine.
  • Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities.
  • Coverage of strategies employed by companies specializing in nanomedicine to meet the challenges of this highly competitive market.

Published - Jan-2012| Analyst - Paul Evers| Code - HLC069B

Report Highlights

The global nanomedicine market reached $43.2 billion in 2010 and $50.1 billion in 2011. The market is expected to grow to $96.9 billion by 2016 at a compound annual growth rate (CAGR) of 14.1% between years 2011 and 2016.

Published - Jan-2010| Analyst - Paul Evers| Code - HLC069A

Report Highlights

  • The global nanomedicine market was valued at $53 billion in 2009, and is forecast to increase at a compound annual growth rate (CAGR) of 13.5% to reach more than $100 billion in 2014. 
  • Nanomedical products for cancer are one of the largets market segments, worth nearly $20 billion in 2009. This sector is expected to increase at a compound annual growth rate (CAGR) of 11% to reach $33 billion in 2014.
  • Nanomedicine for CNS indications is another major market sector, valued at nearly $11 billion in 2009 and expected to reach $18 billion by 2014, an 11.1% compound annual growth rate (CAGR).

Nanotechnology in Medical Applications: The Global Market

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS